Evolent Health, Inc. EVH
3.90 USD +0.47 (+13.70%)
Regular-session close
3.78 -0.12 -3.08%
After hours · Nov 20, 7:43 PM ET
3.45 Day range 4.16
2.17 52-week range 6.19
- YTD
- -2.50%
- 1 year
- +5.69%
News
benzinga.com Gold Falls Sharply; US Consumer Sentiment Rises In November U.S. stocks fell Friday: Dow -0.5%, S&P 500 -2.0%, Nasdaq -3.4%. Tech led losses; consumer staples rose. Gold, silver and global markets also declined.
benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 44.3% to $1.05 during Friday's regular session. The market value of their outstanding shares is at $4.1 million. Akanda (NASDAQ:AKAN) stock moved…
benzinga.com Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday U.S. stocks were mixed as Nasdaq fell over 2%; Buckle surged 7.8% on strong results, while Evolent, Gap and others gained.benzinga.com Truist Securities Upgrades Evolent Health to Buy, Maintains Price Target to $6 Truist Securities analyst Jailendra Singh upgrades Evolent Health (NYSE:EVH) from Hold to Buy and maintains the price target from $6 to $6.
benzinga.com Why Is Humana Stock Trading Higher Tuesday? Humana (HUM) stock jumped over 3% following a new cancer care initiative and a raised 2026 earnings outlook. Read the latest updates.benzinga.com Humana Partners With Evolent Health, American Oncology Network To Introduce New Cancel Care Model In 8 U.S. States Humana Inc., in collaboration with Evolent Health, Inc. and American Oncology Network (AON), today announced the launch of a new cancer care model designed to improve the quality, timeliness and…
benzinga.com Oppenheimer Maintains Outperform on Evolent Health, Raises Price Target to $7 Oppenheimer analyst Michael Wiederhorn maintains Evolent Health (NYSE:EVH) with a Outperform and raises the price target from $6 to $7.
benzinga.com Needham Maintains Buy on Evolent Health, Raises Price Target to $6 Needham analyst Matthew Shea maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $5 to $6.
benzinga.com Evolent Health Q3 2026 Earnings Call Transcript Evolent Health (NYSE:EVH) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…benzinga.com Evolent Health Affirms FY2026 Sales Guidance of $2.600B-$2.700B vs $2.626B Est Evolent Health (NYSE:EVH) affirms FY2026 sales outlook from $2.600 billion-$2.700 billion to $2.600 billion-$2.700 billion vs $2.626 billion estimate.
benzinga.com Evolent Health Q3 Adj. EPS $0.06 Beats $0.05 Estimate, Sales $725.367M Beat $724.186M Estimate Evolent Health (NYSE:EVH) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 20 percent increase over earnings of $0.05 per…
